Bristol-Myers Squibb Earnings
NYSE: BMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$1.62
Bristol-Myers Squibb earnings summary
Bristol-Myers Squibb is scheduled to report Sep/2026 earnings on Oct 29, 2026 before the market opens, with analysts expecting EPS of $1.62. In its most recent report on Jul 30, 2026 (Q2 2026), BMY posted EPS of $1.62. Revenue for the quarter was $12.97 billion.
Quarterly EPS is up 153.1% from the same quarter a year earlier. Across the last 16 reports, BMY shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
BMY earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $1.62 | — | -0.9% |
| Apr 30, 2026 | — | $1.31 | — | -3.5% |
| Feb 11, 2026 | — | $0.54 | — | -0.1% |
| Oct 30, 2025 | — | $1.08 | — | +1.3% |
| Jul 31, 2025 | — | $0.64 | — | +3.9% |
| Apr 24, 2025 | — | $1.20 | — | +5.6% |
| Feb 12, 2025 | — | $0.05 | — | +3.6% |
| Oct 31, 2024 | — | $0.60 | — | -0.3% |
| Jul 26, 2024 | — | $0.83 | — | -3.3% |
| Apr 25, 2024 | — | $-5.89 | — | -1.9% |
| Feb 13, 2024 | — | $0.87 | — | +3.6% |
| Oct 26, 2023 | — | $0.93 | — | +3.5% |
| Jul 27, 2023 | — | $0.99 | — | -1.5% |
| Apr 27, 2023 | — | $1.07 | — | +2.1% |
| Feb 14, 2023 | — | $0.95 | — | -1.3% |
| Oct 26, 2022 | — | $0.75 | — | +2.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.